Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure

NCT01966601 is registered in ClinicalTrials.gov with Trevena Inc. as lead sponsor.

NCT NCT01966601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01966601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure
Lead sponsor
Trevena Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2013
Completion date
September 30, 2016
Enrollment
620 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure